Viavi Solutions Inc. Common Stock
VIAV
$35.87
-2.77%
Viavi Solutions Inc. is a global provider of network test, monitoring, and assurance solutions for communications service providers, enterprises, and government customers, and also supplies high-performance thin-film optical coatings for markets including 3D sensing and anti-counterfeiting. The company operates as a key enabler in the communication equipment industry, providing critical tools for network deployment, optimization, and security. The current investor narrative is heavily focused on a significant strategic pivot and growth acceleration, driven by a major acquisition and partnership activity that has catalyzed a dramatic re-rating of the stock, as evidenced by recent analyst actions and explosive share price performance.…
VIAV
Viavi Solutions Inc. Common Stock
$35.87
Related headlines
VIAV 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Viavi Solutions Inc. Common Stock's 12-month outlook, with a consensus price target around $46.63 and implied upside of +30.0% versus the current price.
Average Target
$46.63
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$29 - $47
Analyst target range
Insufficient analyst coverage available. The data indicates only two analysts providing estimates, with no explicit buy/hold/sell distribution, consensus price target, or target range provided. This limited coverage is atypical for a company of this market cap and suggests it may be under-followed by the broader institutional research community, which can lead to higher volatility and less efficient price discovery. The recent institutional ratings show a pattern of reiterated Buy or Positive ratings from firms like Rosenblatt, Needham, and Stifel throughout 2026, indicating sustained bullish sentiment among the few covering analysts, likely in response to the company's strategic developments.
Bulls vs Bears: VIAV Investment Factors
The bull case, driven by explosive 36% revenue growth and a powerful strategic re-rating, currently holds stronger evidence, as reflected in the stock's 223% annual gain and sustained momentum. However, the bear case presents severe and immediate risks centered on deteriorating profitability and extreme valuation following the massive rally. The single most important tension in the investment debate is whether the company's dramatic revenue acceleration can translate into sustainable profits quickly enough to justify its newly elevated forward PE of 36.6x, or if the current net loss of -$47.8 million signals that the growth is coming at too high a cost.
Bullish
- Explosive Revenue Growth Acceleration: Q2 2026 revenue surged 36.37% YoY to $369.3 million, a dramatic acceleration from prior low-single-digit growth. This is primarily driven by the Product segment, which grew to $317.3 million (86% of revenue), indicating a successful strategic pivot and strong demand for its network equipment.
- Powerful Technical Momentum & Re-rating: The stock has gained 223.31% over the past year and 103.25% over the last three months, decisively breaking out of a multi-year trading range. It trades at 97% of its 52-week high ($38.08), signaling sustained bullish momentum and a fundamental re-rating by the market.
- The company maintains a healthy gross margin of 55.32% (Q2 2026), demonstrating pricing power in its core products. Furthermore, it generated $78.7 million in TTM free cash flow, providing financial flexibility to fund growth despite recent net losses.
- Limited Analyst Coverage with Bullish Bias: The few covering analysts (Rosenblatt, Needham, Stifel) have consistently reiterated Buy or Positive ratings throughout 2026. This concentrated bullish sentiment from specialists suggests deep conviction in the company's new strategic narrative, even as broader institutional coverage remains sparse.
Bearish
- Deteriorating Profitability Amid Growth: Despite soaring revenue, Q2 2026 net income was a loss of -$47.8 million (net margin -12.94%), a significant worsening from the -$21.4 million loss in Q1. This raises questions about the cost structure and scalability of the new growth strategy.
- Extreme Valuation & Price Overextension: The stock trades at a forward PE of 36.62 and a PS of 2.05, near the peak of its own historical valuation range after a 223% rally. Trading at 97% of its 52-week high, it is highly vulnerable to profit-taking and multiple compression if growth expectations falter.
- High Debt & Balance Sheet Strain: The debt-to-equity ratio is 0.89, and the latest cash flow statement shows a significant $600 million debt repayment. This indicates active, potentially costly, balance sheet restructuring that could pressure future cash flows and limit financial maneuverability.
- Volatile Earnings & High Execution Risk: Earnings have been highly volatile, swinging from an $8 million profit in Q4 2025 to a -$47.8 million loss in Q2 2026. This volatility underscores the execution risks associated with integrating acquisitions and scaling new business lines under the strategic pivot.
VIAV Technical Analysis
The stock is in a powerful, sustained uptrend, having appreciated 223.31% over the past year. With a current price of $36.89, it is trading near the top of its 52-week range, approximately 97% of the way towards its 52-week high of $38.08, indicating strong momentum but also potential overextension and vulnerability to profit-taking. Recent momentum remains robust but shows signs of volatility; the stock is up 103.25% over the last three months, yet the 1-month gain of 11.65% suggests the pace of ascent has moderated following the explosive moves seen in late January and early March, which included a single-day surge from $29.71 to $35.35 on March 2nd. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $38.08 and support at the 52-week low of $8.10, though more relevant near-term support likely resides around the $30-$32 level where the stock consolidated in March. The stock's beta of 0.861 indicates it has been less volatile than the broader market during this historic rally, a notable divergence given the magnitude of its gains.
Beta
0.86
0.86x market volatility
Max Drawdown
-23.6%
Largest decline past year
52-Week Range
$8-$38
Price range past year
Annual Return
+263.8%
Cumulative gain past year
| Period | VIAV Return | S&P 500 |
|---|---|---|
| 1m | +28.7% | -2.0% |
| 3m | +93.1% | -4.8% |
| 6m | +179.8% | -2.1% |
| 1y | +263.8% | +30.4% |
| ytd | +97.6% | -3.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VIAV Fundamental Analysis
Revenue growth has accelerated sharply, with the most recent quarterly revenue of $369.3 million representing a 36.37% year-over-year increase, a significant acceleration from the low-to-mid single-digit growth rates seen in prior quarters. This surge is primarily driven by the Product segment, which contributed $317.3 million (86% of total revenue) in the latest quarter, suggesting a major uptick in equipment sales. Profitability has been volatile; the company reported a net loss of $47.8 million and a net margin of -12.94% in Q2 2026, a deterioration from the prior quarter's net loss of $21.4 million, though gross margin remained healthy at 55.32%. The balance sheet and cash flow show a company in transition; free cash flow over the trailing twelve months was a positive $78.7 million, and the current ratio is a solid 1.50, but the debt-to-equity ratio of 0.89 and a significant $600 million debt repayment noted in the latest cash flow statement point to active balance sheet management, likely related to recent strategic moves.
Quarterly Revenue
$369300000.0B
2025-12
Revenue YoY Growth
+0.36%
YoY Comparison
Gross Margin
+0.55%
Latest Quarter
Free Cash Flow
$78700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VIAV Overvalued?
Given the company's negative net income in the most recent quarter, we lead with the Price-to-Sales (PS) ratio for valuation. The trailing PS ratio is 2.05, while the forward PE ratio is 36.62, indicating the market is pricing in a significant recovery in earnings. Compared to industry averages, the valuation is complex; the trailing PE of 63.94 is astronomically high due to depressed earnings, but the more normalized forward PE of 36.62 and PS of 2.05 would need sector averages for proper context, which are not provided in the data. Historically, the stock's own valuation has expanded dramatically; its current PS ratio of 2.05 sits well above its historical range observed in the provided data (which showed figures between 6.08 and 13.21 over the past few years), but this comparison is skewed by a tenfold increase in the share price. The stock is trading near the peak of its own historical valuation spectrum, implying the market has priced in highly optimistic expectations for future growth and margin recovery.
PE
63.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -6294x~306x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's profitability is highly unstable, with Q2 2026 net losses deepening to -$47.8 million despite 36% revenue growth, indicating a severe cost absorption problem. The debt-to-equity ratio of 0.89 and a major $600 million debt repayment highlight balance sheet strain, which could constrain future investments. Furthermore, revenue concentration in the Product segment (86% of total) creates dependency on lumpy equipment sales cycles, increasing earnings volatility.
Market & Competitive Risks are elevated due to valuation. The stock trades at a forward PE of 36.62 and near its 52-week high after a 223% rally, making it acutely susceptible to multiple compression if growth decelerates or market sentiment sours. Its beta of 0.86 suggests it has been less volatile than the market during its run-up, but this divergence increases the risk of a sharp mean-reversion. The strategic pivot into defense and security (hinted at by news) also introduces new competitive and execution risks in unfamiliar markets.
The Worst-Case Scenario involves the company failing to convert its revenue surge into profits, triggering analyst downgrades and a rapid de-rating. A chain of events where the next quarter shows continued deep losses and slowing growth could lead to a violent sell-off. The realistic downside could see the stock retreat to its recent consolidation support near $30 (a -19% drop from $36.89) or, in a severe bear case, test levels closer to its 52-week low of $8.10, representing a catastrophic -78% loss. A more probable adverse scenario would be a -30% to -40% correction to the mid-$20s, aligning with a reversion to its pre-breakout valuation multiples.